20 results for "Veronica Codullo"

Scleroderma renal crisis: Case reports and update on critical issues

Elisabetta Zanatta; Veronica Codullo; Yannick Allanore

European Journal of Rheumatology, Vol. 8 No. 3 · 2021 · English · DOAJ

Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them?

Domenico Sambataro; Gianluca Sambataro; Francesca Pignataro et al.

Diagnostics, Vol. 10 No. 4 · 2020 · English · DOAJ Scopus

The diagnostic assessment of patients with Interstitial Lung Disease (ILD) can be challenging due to the large number of possible causes. Moreover, the diagnostic approach can be limited by the severity of the disease, which may not allow invasive exams. To overcome this issue, the referral centers…

Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study

Claudio Tirelli; Valentina Morandi; Adele Valentini et al.

Frontiers in Medicine, Vol. 7 · 2020 · English · DOAJ Scopus

Interstitial lung disease (ILD) encompasses a wide range of parenchymal lung pathologies with different clinical, histological, radiological, and serological features. Follow-up, treatment, and prognosis are strongly influenced by the underlying pathogenesis. Considering that an ILD may complicate…

Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian study

Paolo Airo; Veronica Codullo; Elisabetta Zanatta et al.

RMD Open, Vol. 12 No. 2 · 2026 · English · DOAJ Scopus

Background Tocilizumab (TCZ) has shown beneficial effects on interstitial lung disease (ILD) in systemic sclerosis (SSc). We aimed to assess the real-life safety and effectiveness of TCZ on several SSc-related domains using data from a French-Italian multicentre cohort.Methods We conducted a…

CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis

Claudio Tirelli, MD; Giovanni Zanframundo, MD; Adele Valentini, MD et al.

Radiology Case Reports, Vol. 15 No. 11 · 2020 · English · DOAJ Dropped by Scopus 2024

Pulmonary involvement in Sjogren syndrome (SS) could manifest as cystic lung disease (CLD). CLD in SS includes lymphocytic interstitial pneumonia (LIP) and pulmonary amyloidosis. Differential diagnosis usually requires surgical lung biopsy, whereas CT-guided percutaneous fine needle aspiration…

P39 Analysis of nailfold capillaroscopy findings and clinical features of patients with systemic lupus erythematosus and pulmonary arterial hypertension

Carlo Alberto Scirè; Alessandra Bortoluzzi; Micaela Fredi et al.

Lupus Science and Medicine, Vol. 11 No. Suppl 1 · 2024 · English · DOAJ Scopus

Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis

Laura Pandolfi; Sara Bozzini; Vanessa Frangipane et al.

Frontiers in Immunology, Vol. 12 · 2021 · English · DOAJ Scopus

The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to…

Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort

Carlo Alberto Scirè; Alessandra Bortoluzzi; Micaela Fredi et al.

Lupus Science and Medicine, Vol. 12 No. 1 · 2025 · English · DOAJ Scopus

Objectives The aim of our work was to identify specific patterns in clinical features and nailfold capillary changes that may help in screening for pulmonary arterial hypertension (PAH) in patients with systemic lupus erythematosus (SLE).Methods We identified patients with SLE and type I PAH (n=20)…

Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy

Lorenzo Cavagna; Elena Seminari; Giovanni Zanframundo et al.

Microorganisms, Vol. 8 No. 7 · 2020 · English · DOAJ Scopus

The role of immunosuppression in SARS-CoV-2-related disease (COVID-19) is a matter of debate. We here describe the course and the outcome of COVID-19 in a cohort of patients undergoing treatment with calcineurin inhibitors. In this monocentric cohort study, data were collected from the COVID-19…

Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study

Chiara Tani; Chiara Cardelli; Roberto Depascale et al.

Journal of Translational Autoimmunity, Vol. 7 · 2023 · English · DOAJ Scopus

Background: Vaccination is one of the most important measures to contain the COVID-19 pandemic, especially for frail patients. VACCINATE is a multicentre prospective observational study promoted by the European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases…

In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case–control study

Jérémie Sellam; Laurent Arnaud; Marta Mosca et al.

RMD Open, Vol. 9 No. 3 · 2023 · English · DOAJ Scopus

Background Some myopathies can lead to dropped head or bent spine syndrome (DH/BS). The significance of this symptom has not been studied in inflammatory myopathies (IM).Objectives To assess the significance of DH/BS in patients with IM.Methods Practitioners from five IM networks were invited to…

Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohortsAnti–type I IFN auto-Abs in WNV encephalitis

Adrian Gervais; Francesca Trespidi; Alessandro Ferrari et al.

Journal of Human Immunity, Vol. 2 No. 3 · 2026 · English · DOAJ Scopus

In 13 cohorts of individuals with WNV infection, the risk of WNV encephalitis is increased 20 to >>2,000 times by circulating auto-Abs neutralizing type I IFNs, depending on the concentration and combination of type I IFNs neutralized and patient age.

Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR)

Martina Orlandi; Dilia Giuggioli; Clodoveo Ferri et al.

Therapeutic Advances in Musculoskeletal Disease, Vol. 17 · 2025 · English · DOAJ Scopus

Background: Hormonal changes in menopause might interact with the presentation of underlying autoimmune diseases, such as systemic sclerosis (SSc). Objectives: Our study aimed to evaluate the association of (1) current menopausal status, (2) early menopause, and (3) disease onset during fertile or…

Age and onset timing of Raynaud’s phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR)

Silvia Peretti; Cosimo Bruni; Francesco Bonomi et al.

Therapeutic Advances in Musculoskeletal Disease, Vol. 18 · 2026 · English · DOAJ Scopus

Background: The sequence and temporal relationship between Raynaud’s phenomenon (RP) and the first non-Raynaud’s sign/symptom (NRP) in systemic sclerosis (SSc) have been partially investigated. Objectives: To evaluate whether the mode and ages of clinical onset are associated with disease endotype…

Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase

Clodoveo Ferri; Vincenzo Raimondo; Dilia Giuggioli et al.

Journal of Translational Autoimmunity, Vol. 7 · 2023 · English · DOAJ Scopus

Introduction: The impact of COVID-19 pandemic represents a serious challenge for ‘frail’ patients' populations with inflammatory autoimmune systemic diseases such as systemic sclerosis (SSc). We investigated the prevalence and severity of COVID-19, as well the effects of COVID-19 vaccination…

Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology

Andrea Doria; Marcello Govoni; Gerolamo Bianchi et al.

RMD Open, Vol. 12 No. 2 · 2026 · English · DOAJ Scopus

Background Antitopoisomerase I (ATA), anticentromere (ACA) and anti-RNA polymerase III (RNAP3) antibodies are included in the 2013 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for systemic sclerosis (SSc). A subset of patients with SSc…

Unmet needs and challenges in the diagnosis and management of antiphospholipid syndrome: a qualitative stakeholder study within the ReCONNET framework

Rosaria Talarico; Zahir Amoura; Tadej Avcin et al.

Lupus Science and Medicine, Vol. 12 No. 2 · 2025 · English · DOAJ Scopus

Objective Antiphospholipid syndrome (APS) is a rare autoimmune condition characterised by thrombosis and/or pregnancy morbidity in the presence of antiphospholipid antibodies. Despite the publication of updated American College of Rheumatology (ACR)/European Alliance of Associations for…

Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study

Carlo Alberto Scirè; Alessandra Bortoluzzi; Andrea Doria et al.

RMD Open, Vol. 10 No. 2 · 2024 · English · DOAJ Scopus

Objectives To investigate pregnancy outcomes in women with autoimmune rheumatic diseases (ARD) in the Italian prospective cohort study P-RHEUM.it.Methods Pregnant women with different ARD were enrolled for up to 20 gestational weeks in 29 Rheumatology Centres for 5 years (2018–2023). Maternal and…

Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort

Pavel I Novikov; Thierry Martin; Eric Hachulla et al.

RMD Open, Vol. 8 No. 2 · 2022 · English · DOAJ Scopus

Objectives Tocilizumab showed trends for improving skin fibrosis and prevented progression of lung fibrosis in systemic sclerosis (SSc) in randomised controlled clinical trials. We aimed to assess safety and effectiveness of tocilizumab in a real-life setting using the European Scleroderma Trial…

Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology

Carlo Alberto Scirè; Andrea Doria; Marcello Govoni et al.

RMD Open, Vol. 9 No. 1 · 2023 · English · DOAJ Scopus

Objective To describe demographic, clinical and laboratory features of systemic sclerosis sine scleroderma (ssSSc) in a large multicentre systemic sclerosis (SSc) cohort.Methods Data involving 1808 SSc patients from Italian Systemic sclerosis PRogression INvestiGation registry were collected. The…